MENU
SWTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
SpringWorks Therapeutics (SWTX) Ownership - Who owns SpringWorks Therapeutics?
Profile
Industry
N/A
Address
100 Washington Boulevard
Phone
+1 203 883-9490
Employees
305
Web
https://www.springworkstx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.81B
P/E Ratio
N/A
Total Cash
376.62M
Projected Growth
N/A
Total Debt
6.91M
Revenue
135.49M
Risk (Beta)
0.66
Dividend Yield
N/A
Total Cash/Share
5.06
Total Debt/Equity
N/A
Revenue/Share
1.89 USD as % of share price
Fundamentals
SWTX
Capitalization
2.81B
P/E Ratio
N/A
Risk (Beta)
0.66
Dividend Yield
N/A
Total Cash
377M
Total Cash/Share
5.06
Total Debt
6.91M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.89%
Revenue
135M
ROE
N/A
Book Value
533M
P/B Ratio
5.27
Cash Flow
N/A
Earnings
-3.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
6.16
Current Revenue Per Employee
161642.62
Dividends Per Share - Security
N/A
EBITDA
-292.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
93.22
Revenue To Assets
-51.12
Shares Held By Institutions
4.65B
Shares Outstanding - Current
74.4M
Total Liabilities
76.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
3.342
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 Washington Boulevard
Phone
+1 203 883-9490
Employees
305
Web
https://www.springworkstx.com